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INTRODUCTION 
Although cardiovascular disease is still the leading causes of death globally, one has 
to realize that it is mainly well treatable when detected on time. Accordingly, 
cardiovascular death is well preventable with careful and appropriate medical care. 
Therefore, accurate definition and diagnosis of significant or clinically relevant 
coronary artery disease has been in the focus of interest since the first coronary 
stenosis was diagnosed by angiography.  
Note, when aiming to change prognosis, the main determinant factor is not the 
angiographic severity of a coronary stenosis by itself, but the true presence and 
extent of ischemia. Therefore benefit from revascularization can be only expected 
when it eliminates ischemic risk.  
The angiographic cut-off value to determine significant coronary artery disease is 
derived from early animal experiences, linking morphologic severity to reduction of 
coronary blood flow. As angiographic judgment is really simple and straight-
forward to obtain, it is generally applied to guide clinical decision-making. However, 
angiography allows only indirect evaluation of functional importance, and so its 
accuracy on individual basis can be uncertain. This limitation of pure angiographic 
diagnosis has been circumvented by the development of pressure measuring guide 
wires and the invention of the concept of fractional flow reserve. 
Fractional flow reserve is defined as the ratio of maximal hyperemic myocardial 
blood flow in the presence of a stenosis to the physiologic maximal hyperemic 
myocardial blood flow in the same territory but in the absence of any stenosis. Thus, 
the value of fractional flow reserve quantifies to what extent hyperemic flow is 
reduced by the presence of the epicardial narrowing. The value of fractional flow 
reserve is calculated as the ratio of distal coronary artery pressure and aortic pressure 
during maximal hyperemia. 
Thanks to all technical and conceptual advantages, after 20 years fractional flow 
reserve became the standard of reference to define the ischemic potential of 
epicardial stenoses of intermediate angiographic severity.   
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OBJECTIVES 
Despite powerful outcome data and the highest level of recommendation by 
European revascularization guidelines the adaptation of fractional flow reserve by 
the interventional cardiologists community is still limited. Indeed, there might be 
some important questions regarding the concept, causing potential hesitation against 
its unlimited clinical applicability.  
(1) In daily practice the vast majority of decisions about revascularization are 
based on diameter stenosis as gauged by visual estimation or computerized 
quantification on coronary angiogram. Anatomic severity on quantitative coronary 
angiography is an oversimplified measure of stenosis severity that do not account for 
all aspects of severity, especially in case of ‘intermediate’ stenosis. Accordingly, 
the first goal of the present work is to analyze the concordance or discordance 
between stenosis severity by quantitative coronary angiography and by 
fractional flow reserve in a large unselected patient cohort. (Quantitative 
Coronary Angiography versus Fractional Flow Reserve study)  
(2) The formula of fractional flow reserve calculation is simplified by 
excluding the right atrial pressure, considered to be negligibly low compared to the 
arterial values and so it would have limited impact on the calculated fractional flow 
reserve value. Ever since, this assumption has been confirmed and supported by the 
excellent clinical outcome data. However, as field of application got wider, debates 
have risen again about fractional flow reserves’ universal applicability and validity 
including patients with elevated right atrial pressures, such as patients with 
myocardial or valvular heart failure. Accordingly, the second goal of this work 
was to assess the impact, if any, of a wide range of right atrial pressures on 
fractional flow reserve assessment (myocardial fractional flow reserve) and on 
fractional flow reserve-guided clinical decision-making. (Fractional Flow 
Reserve vs Myocardial Fractional Flow Reserve study)  
(3) As, only under conditions of maximal hyperemia does the pressure ratio 
between the distal coronary artery and aorta equal the maximum flow ratio between 
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stenotic and normal conditions, the cornerstone of fractional flow reserve 
measurement is the reliable and stable maximal hyperemia. Despite the widespread 
adoption of intracoronary adenosine, a recurring debate still exists regarding its 
optimal dose, as no prior study has created sufficiently detailed and convincingly 
extensive dose-response curve in humans. The sense or non-sense of applying 
extreme dosages of adenosine is a recurring issue, requiring clarification. Therefore, 
the third goal of this work is to define the dose-response relationship between 
intracoronary adenosine and its resulting hyperemia. (Dose-response study) 
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METHODS 
Quantitative Coronary Angiography versus Fractional Flow Reserve study 
Study population 
2.986 patients underwent both quantitative coronary angiography and fractional flow 
reserve measurements in at least one stable coronary artery stenosis.  
Quantitative coronary angiography 
Quantitative coronary angiography was performed based on computerized 
technology (Siemens Healthcare Axiom Artis, Siemens Healthcare ACOM.PC 5.01 
or General Electric AW VolumeShare 6E). The contrast-filled catheter was used for 
calibration. From an end-diastolic still-frame, reference diameter, minimum luminal 
diameter, percent diameter stenosis and lesions length were calculated.  
Fractional flow reserve measurement 
Fractional flow reserve was measured after intracoronary administration of 
isosorbide dinitrate (200 µg). A pressure monitoring guide wire was advanced distal 
to the coronary artery stenosis. Hyperemia was obtained after administration of 
intravenous adenosine (continuous infusion of 140 µg/kg/min), intracoronary 
adenosine (bolus of 50-150 µg) or intracoronary papaverine (bolus of 10-20 mg). A 
fractional flow reserve value ≤0.80 was considered ‘positive’, i.e. likely to induce 
reversible myocardial ischemia. A fractional flow reserve value >0.80 was 
considered ‘negative’, i.e. unlikely to induce reversible myocardial ischemia.  
Fractional Flow Reserve versus Myocardial Fractional Flow Reserve study  
Study population 
1.235 patients underwent both left- and right heart catheterization and fractional 
flow reserve measurement in at least one coronary stenosis. 
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Left and right heart catheterization 
Diagnostic catheters were used for obtaining pressure values in the left heart, 
including aortic and left ventricular pressures. Swan-Ganz catheter was used for 
obtaining pressure values in the right heart, including right atrial-, right ventricular-, 
pulmonary arterial- and pulmonary capillary wedge pressures.  
Fractional flow reserve measurement 
Fractional flow reserve measurement was performed as described above. Fractional 
flow reserve was defined as the ratio of the simultaneously recorded mean arterial 
pressure distal to the stenosis and the mean aortic pressure at the tip of the guiding 
catheter during stable, steady state hyperemia. Myocardial fractional flow reserve 
was defined as the ratio of mean distal coronary pressure minus mean right atrial 
pressure, and the mean aortic pressure minus mean right atrial pressure during stable, 
steady state hyperemia. 
Dose-response study 
Study population 
Patients with stable coronary artery disease undergoing routine diagnostic coronary 
angiography for a variety of indications were approached for participation. All 
patients had documented coronary atherosclerosis, but the measurements were 
performed in vessels free of any stenosis with more than 20% diameter reduction. 
Intracoronary Doppler velocity measurement 
Coronary flow velocity measurements were performed with Doppler sensor tipped 
guide wire. Flow velocity was measured in under following conditions: (1) resting 
conditions; then after administration of 8 mL (2) arterial blood; (3) pure saline at 
room temperature; (4) contrast medium (iodixanol 270 mg/mL); then after 
administration of (5-13) 9 escalating doses of adenosine [4, 12, 20, 60, 100, 160, 200, 
300, and 500 µg / 8 mL]; and finally after administration of (10) 200 µg of 
adenosine plus contrast medium in 8 mL. 
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Statistical Analysis 
All analyses were performed with Prism GraphPad 5.0 (GraphPad Software Inc., 
California, US), SPSS 20.0 (IBM Inc., New York, US) and R version 3.1.2 (R 
Foundation for Statistical Computing, Vienna, Austria) with standard summary 
statistics. p<0.05 was considered statistically significant. Normal distribution was 
tested with the D’Agostino-Pearson omnibus K2 test. Unpaired t-test or Mann-
Whitney test were used to compare two independent groups, as appropriate. To 
compare multiple groups one-way ANOVA or Kruskal-Wallis test were used, as 
appropriate. Correlation among variables was determined by Pearson or Spearman 
correlation tests, as appropriate and expressed in r value. Sensitivity, specificity, 
diagnostic accuracy, and optimal diagnostic cut-off value were defined from the 
calculated receiver operator characteristic curves, as appropriate. Logistic regression 
analysis was performed to assess the impact of various characteristics on the 
accuracy of 50% diameter stenosis cut-off value in predicting FFR ≤ 0.80.  
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RESULTS 
Quantitative Coronary Angiography versus Fractional Flow Reserve study 
Data from 4.086 coronary artery stenoses in 2.986 patients were analyzed. Fractional 
flow reserve was in median 0.82 (0.74; 0.88) diameter stenosis was 48% (39; 57). 
Overall relationship between angiographic metrics and fractional flow reserve 
The relationship between diameter stenosis and fractional flow reserve was only 
modest but statistically significant (-0.38 [95% CI: -0.41; -0.36]; p<0.001) with 
marked scatter around the regression line. Figure 1. A diameter stenosis ≥50% 
correctly identified a fractional flow reserve value ≤ 0.80 with a sensitivity of 61% 
[95% CI: 59; 63] and a specificity of 67% [95% CI: 65; 69], associated with a 
diagnostic accuracy of 0.64 [95% CI: 0.56; 0.72].  
 
Figure 1 – Correlation between diameter stenosis and 
fractional flow reserve.  
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Influence of patients’ characteristics 
Two parameters, namely male gender (p=0.017) and presence of diabetes (p=0.005) 
were found to influence negatively the value of 50% diameter stenosis cut-off in 
predicting significant fractional flow reserve. 
Diagnostic performance of 50% versus 70% diameter stenosis 
The overall diagnostic performance of angiography is significantly weaker when a 
70% diameter stenosis is considered as cut-off value (Youden index 0.30 (0.28; 
0.32) vs 0.08 (0.06; 0.12), respectively; p=0.004).  
Optimal angiographic cut-off values for percent diameter stenosis 
The optimal cut-off values of diameter stenosis for predicting fractional flow reserve 
≤0.80 were markedly different: 43% for the left main stem, 51% for the global 
population, 55% for the distal segments. 	  
Fractional Flow Reserve versus Myocardial Fractional Flow Reserve study  
Data from 1.676 coronary artery stenoses in 1.235 patients were analyzed. Indication 
for catheterization was heart failure with NYHA Class II-IV in 914 patients (74%), 
ischemic heart disease in 642 patients (52%) and concomitant valve heart disease in 
593 patients (48%).  
Average fractional flow reserve value was 0.85 (0.78; 0.91), while average 
myocardial fractional flow reserve was 0.83 (0.76; 0.90). Correlation and agreement 
between the two parameters were excellent (r2=0.987; slope 1.096±0.003). The 
median difference was 0.01 (0.01; 0.02). (Figure 2) 
Relationship between FFR and FFRmyo 
In patients, having normal right atrial pressure (Pra ≤5mmHg) median difference 
between fractional flow reserve and myocardial fractional flow reserve was 
minimal: 0.01 (0.00; 0.01). When grouping the patients into tertiles of Pra, a 
significant increase was observed in the difference between fractional flow reserve 
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and myocardial fractional flow reserve over the three groups [0.01 (0.00; 0.01) vs. 
0.01 (0.01; 0.02) vs. 0.02 (0.01; 0.03), respectively; p<0.001].  
 
Figure 2 – Correlation between fractional flow reserve 
and myocardial fractional flow reserve. 
 
Out of 1.146 stenoses with fractional flow reserve above 0.80, none had a 
myocardial fractional flow reserve equal to or below 0.75; and 110 (9%) stenoses 
had a myocardial fractional flow reserve equal to or below 0.80. In the latter group 
the difference was 0.02 (0.02; 0.03), yet with right atrial pressure significantly 
higher than in the overall population [9 (7; 12) mmHg; p<0.001].  
Dose-response study 
30 patients were investigated. Coronary flow reserve varied from 1.42 to 4.88. The 
baseline flow velocity was higher in patients with a low coronary flow reserve than 
in patients with a high coronary flow reserve (29±11 cm/s versus 16±7 cm/s; 
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p<0.001). Hyperemic flow velocity was similar in both groups (61±26 cm/s versus 
55±17 cm/s; p=0.41). 
Dose-response analysis 
Figure 3 summarizes the dose-response relationships of intracoronary adenosine in 
the left- and the right coronary artery.  
 
Figure 3 – Adenosine dose-response relation in the left- and in the right 
coronary artery. 
 
For the right coronary artery baseline-to-maximal flow did not increase significantly 
at any higher dose than 60 µg. For the left coronary artery baseline-to-maximal flow 
did not increase significantly at any higher dose than 160 µg. 
Effect of blood, saline and contrast medium 
Doppler flow velocity varied among 8 mL intracoronary boluses of arterial blood, 
saline and contrast (p<0.001 by ANOVA), and all pairwise comparisons were 
significant (p<0.001 for blood and contrast; p=0.041 for saline and blood; p=0.013 
for saline and contrast). Contrast increased Doppler flow velocity the most 
(+38±52% over blood, p<0.001 by paired t-test; +17±28% over saline, p=0.019) and 
saline was superior to blood (+21±43%, p=0.008). Flow velocity after contrast 
medium reached 65±36% of the value reached after 200 µg of adenosine.  
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CONCLUSIONS  
Present work reports data from the largest patient population in the topic so far about 
the comparison of angiographic metrics and functionality. Our results emphasize 
that reliance on the angiogram needs to be modified by physiologic measures of 
severity for a wide range of intermediate stenoses. Explaining the results of 
randomized trials, showing outcome benefit associated with fractional flow reserve-
guidance, we found that as much as one third of the decisions based angiographic 
metrics are discordant with the fractional flow reserve. Data show that increasing the 
threshold to 70% improved the specificity (i.e. will decrease the trend of coronary 
angiography to overestimate lesion severity, resulting potentially in unnecessary 
revascularization) but decreased sensitivity (i.e. will increase the number of stenoses 
underestimated by coronary angiography, resulting potentially in untreated risk left 
behind). Summed, increasing the threshold to 70% decreases the overall diagnostic 
performance of diameter stenosis in predicting significant fractional flow reserve, as 
compared to 50% cut-off value.  
In this work we investigated on the largest patient population so far, affected by 
various degree of heart failure of different etiologies, whether incorporating the 
value of right atrial pressure into the formula (myocardial fractional flow reserve) 
has any clinical impact on fractional flow reserve measurement. Although these 
patients had a right atrial pressure often markedly above the normal range, the 
correlation and the agreement between measured fractional flow reserve and 
calculated myocardial fractional flow reserve was still excellent, with a difference as 
minimal as 0.01. In no case a fractional flow reserve value above 0.80 turned to a 
myocardial fractional flow reserve below 0.75. Summarizing, our findings indicate 
that accounting for actual value of right atrial pressure induces only minimal 
differences in the calculations of FFR, on average within the limits of the test-retest 
repeatability. In addition, these differences have negligible clinical consequences 
even in patients with elevated right atrial pressure.  
 12 
The present dose-response study of intracoronary adenosine on intracoronary 
Doppler flow velocity suggests that optimal bolus to induce maximal hyperemia 
consistently, reliably and safely is 60-100 µg for the right coronary artery and 160-
200 µg for the left coronary artery. Sequential doses above the indicated amounts 
showed no statistically significant further increase in flow. Notably, we observed an 
increased incidence of AV-block at higher doses. Based on the findings of our dose-
response analysis a clear recommendation can be made for the optimal dosing of 
adenosine for the measurement of fractional flow reserve. These doses allow 
achieving >95% of maximum hyperemia and are clinically indistinguishable from 
higher dosages. While lower doses are less reliable to reach maximal hyperemia, 
therefore inducing inaccuracy of our measurement with potential underestimation of 
lesion severity.  
Summary 
This work investigated important topics, and we believe, a couple of crucial 
questions have been answered, facilitating an even broader acceptance of fractional 
flow reserve: 
This work confirms on the largest population so far what massive discrepancies can 
be observed between angiographic severity of a stenosis and its true ischemic 
potential.  
Dose-response data gives recommendation for optimal hyperemia induction, and 
confirms that any decrease in adenosine dosages impacts negatively the accuracy, 
while further increase dosages does not have any benefit, therefore can be 
considered as non-sense. 
Data confirm that right atrial pressure has no relevant impact on the fractional flow 
reserve value, not even in patients with pathologically elevated central venous 
pressures.  
We believe these findings have the potential to impact future interventional practices. 
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